Cardiovascular disease (CVD) is the most common cause of death and disability in female patients with a steady increase in incidence. Available data suggest that there are significant differences between men and women in CVD epidemiology, diagnostic procedures, prognosis and effects of the treatment. A series of open questions reflect differences in CVD risk that are defined by different hormonal status throughout the life in men and women. Different sensitivity and specificity for a number of diagnostic cardiovascular tests is described for female patients, as well as the uneven response to the therapy in the practically same clinical 3. Cooper R, Cutler J, Desvigne-Nickens P, et al. Trends and disparities in coronary heart disease. Circulation. 2000;102:3137-47. circumstances. Also, the mortality from CVD is higher in women than in men. It might be explained by a higher median age and a higher degree of comorbidity. It is still not possible to give precise answers to a number of open questions in this field which is mostly due to the fact that women are generally underrepresented in randomized controlled trials. A similar relationship can be found in the studies that examine the diagnostic and/or therapeutic cardiovascular procedures. Nevertheless, we should be aware that women are more often prescribed nitrates, calcium channel blockers, diuretics and sedatives, but in a minor percentage they receive beta-blockers, statins and aspirin than men. In this review, we have analyzed the available scientific sources on cardiovascular morbidity in women with a special emphasis on open issues and priorities for the future studies.
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